Lebrikizumab maintenance dosing achieves dermatitis clearance up to 2 years

Press/Media

Period	26 Oct 2023

Media coverage

Title	Lebrikizumab maintenance dosing achieves dermatitis clearance up to 2 years
Media name/outlet	Healio
Country/Territory	United States
Date	26/10/23
URL	https://www.healio.com/news/dermatology/20231026/lebrikizumab-maintenance-dosing-achieves-dermatitis-clearance-up-to-2-years
Persons	Emma Guttman